Concepedia

Harshini Asogan

HA

9

Publications

2K

Citations

9

H-Index

2016

Active since

Affiliations

King's College London(Current)

University of Oxford

University of Nottingham

University of Bristol

Nottingham University Hospitals NHS Trust

Harshini Asogan is an author at King's College London specializing in medicine, infection control, and clinical microbiology.

Top concepts

MedicineCovid-19Infection ControlClinical MicrobiologyAntibioticsEpidemiologyPublic HealthClinical TrialsHospital MedicineAntimicrobial Resistance

Publications per year

2016–2024

9

Publications

9

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 555 citations · Full text

Long Covid, Antimicrobial Stewardship, Antibiotics +7

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 516 citations · Full text

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 382 citations · Full text

Covid-19 Pandemic, Antiviral Therapy, Clinical Trials +3

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 289 citations · Full text

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2023 · 126 citations · Full text

Rows per page

1–5 of 9